BeStock  
Stocks › Biotechnology › GENB

Generate Biomedicines GENB

US equityMarket cap rank #3024Biotechnology
$9.54 −$0.83 (-8.00%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $9.90 +3.77%
Open$10.06
Prev close$10.37
Day range$9.40 – $10.58
Volume967.9K
Market cap$1.23B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership83.2%+4.85 pts vs. prior quarter
Institutions holding120+16 vs. prior quarter
Insider trades (recent)19 buys / 3 sellsNet buying
ARK fund activity+304,851 sh1 recent transactions · last 25 Aug 2026
Short interest7.08% of floatDays to cover 8.9 · as of 30 Oct 2026
Short-sale volume share25.1%5-day average of daily volume

Short-sale volume as % of daily volume

16%24%32%40%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$1.47M (11 inflow days, 9 outflow days).

Net flow by order size, last 20 sessions

−$655.9KSuper−$814.3KBig−$405.7KMid−$83.1KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 62.5% of shares outstanding.

Largest holders

  • Flagship Pioneering, Inc48.83%
  • FMR5.60%
  • Capital Research3.27%
  • Braidwell LP2.56%
  • Michael Nally2.25%
  • Vanguard Capital Management, LLC1.74%
  • T. Rowe Price Group, Inc.1.68%
  • Norges Bank Investment Management1.63%

By investor type

  • VC/PE Fund53.95%
  • Mutual Fund19.54%
  • Hedge Fund5.08%
  • Individual/Insider4.07%
  • Sovereign Wealth Fund1.63%
  • Private Company1.51%
  • Endowment Fund0.87%
  • Public Company0.61%

Reported short interest has risen from 5.68% to 7.08% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
FMR Mutual Fund 2026/Q3 +1,964,604 5.6%
Banque Pictet & Cie SA Private Company 2026/Q3 +1,789,709 1.4%
J.P. Morgan Asset Management, Inc. Mutual Fund 2026/Q3 +1,244,231 2.0%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +1,102,840 1.7%
ARK Investment Management LLC Mutual Fund 2026/Q3 +680,044 1.5%
BlackRock Mutual Fund 2026/Q3 +170,234 1.4%
Morgan Stanley Public Company 2026/Q3 +144,416 0.4%
Morgan Stanley Investment Management Inc. Mutual Fund 2026/Q3 +144,416 0.4%
Savant Capital, LLC Mutual Fund 2026/Q3 +139,418 0.1%
TD Asset Management Mutual Fund 2026/Q3 +129,252 0.1%
Bank Pictet & Cie (Europe) AG Private Company 2026/Q3 +77,778 0.1%
BNP Paribas Financial Markets SNC Private Company 2026/Q3 +58,720 0.0%
Bolton Securities Corporation Private Company 2026/Q3 +45,000 0.0%
Dynamic Advisor Solutions LLC Mutual Fund 2026/Q3 +40,816 0.0%
Norges Bank Investment Management Sovereign Wealth Fund 2026/Q3 +2,094,616 1.6%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
28 Oct 2026 Frances Arnold Independent Director Automatic Disposition -11,409 $16.19 452,535
1 Sep 2026 Frances Arnold Independent Director Intent to Sell (Form 144) -32,210 $16.16 –
31 Aug 2026 Frances Arnold Independent Director Automatic Disposition -1,000 $16.00 463,944
3 Mar 2026 Michael Nally Chief Executive Officer Open Market Acquisition +20,000 $12.00 2,889,154
1 Mar 2026 Jane Mendillo Independent Director Private Acquisition +1,500 $16.00 1,500
1 Mar 2026 Stéphane Bancel Independent Director Derivative Exercise and Retained +724,160 – 1,184,989
1 Mar 2026 Michael Nally Chief Executive Officer Derivative Exercise and Retained +658,327 – 2,869,154
1 Mar 2026 Beth Grous Chief Human Resources Officer Private Acquisition +300 $16.00 300
1 Mar 2026 Jason Silvers President Private Acquisition +2,000 $16.00 1,500
25 Feb 2026 Flagship Pioneering, Inc Initial Statement of Beneficial +0 – 25,016,458
25 Feb 2026 Noubar Afeyan Co-founder & Independent Chair of the Board Initial Statement of Beneficial +0 – 65,832
25 Feb 2026 Paul Parker Independent Director Other Derivative Acquisition +29,561 $16.00 29,561
25 Feb 2026 Paul Parker Independent Director Initial Statement of Beneficial +0 – 131,665
25 Feb 2026 Marsha Fanucci Independent Director Other Derivative Acquisition +29,561 $16.00 29,561
25 Feb 2026 Marsha Fanucci Independent Director Initial Statement of Beneficial +0 – 131,665
25 Feb 2026 Nancy Simonian Independent Director Other Derivative Acquisition +29,561 $16.00 29,561
25 Feb 2026 Nancy Simonian Independent Director Initial Statement of Beneficial +0 – 131,665
25 Feb 2026 Frances Arnold Independent Director Other Derivative Acquisition +29,561 $16.00 29,561
25 Feb 2026 Frances Arnold Independent Director Initial Statement of Beneficial +0 – 98,748
25 Feb 2026 Jane Mendillo Independent Director Other Derivative Acquisition +29,561 $16.00 29,561

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 9,084,724 7.1% 8.9
15 Oct 2026 8,930,609 7.0% 8.0
30 Sep 2026 7,417,094 5.8% 5.8
15 Sep 2026 7,180,013 5.6% 7.2
31 Aug 2026 7,456,033 5.8% 3.7
14 Aug 2026 7,286,295 5.7% 15.1

Discussion

No comments yet — be the first to weigh in on GENB.

Sign in to join the discussion.

Scroll to Top